Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Widespread Acceptance Of Immunoglobulin-Based Therapies
3.2.2. Growing Usage Of Albumin In Other Therapeutic Areas
3.2.3. Growing Geriatric Population
3.2.4. Rising Prevalence Of Alpha-1 Antitrypsin Deficiency (Aatd)
3.2.5. Increase In The Patient Pool For Hemophilia Treatment
3.3. Key Restraints
3.3.1. Increasing Usage Of Recombinant Plasma Products In Therapeutic Treatments
3.3.2. High Costs Of Blood Plasma Treatments
3.3.3. Adverse Reactions Associated With Post-Transfusion
3.3.4. Spread Of Pathogenic Contaminants
3.3.5. High Regulations In The Market

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Plasma Therapeutics Regulation
4.3. Clinical Guidelines
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Mode Of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants

6. Market By Disorder
6.1. Immunodeficiency Disease
6.2. Hypogammaglobulinemia
6.3. Hemophilia
6.4. Von Willebrand Disease (Vwd)
6.5. Other Disorders

7. Market By Blood Plasma Derivatives
7.1. Immunoglobulin
7.1.1. Intravenous Immunoglobulin
7.1.2. Subcutaneous Immunoglobulin
7.1.3. Other Immunoglobulin Types
7.2. Albumin
7.3. Hyperimmune
7.4. Coagulation Factor Concentrates
7.5. Other Plasma Fractionation Products

8. Market By Therapeutic Indication
8.1. Neurology
8.2. Immunology
8.3. Oncology
8.4. Transplantation
8.5. Hematology
8.6. Rheumatology
8.7. Pulmonology
8.8. Other Therapeutic Indication

9. Market By End-User
9.1. Hospitals And Clinics
9.2. Research Laboratories
9.3. Academic Institutions

10. Geographical Analysis
10.1. Asia Pacific
10.1.1. Japan
10.1.2. China
10.1.3. Australia & New Zealand
10.1.4. India
10.1.5. South Korea
10.1.6. Thailand
10.1.7. Indonesia
10.1.8. Vietnam
10.1.9. Rest Of Asia Pacific

11. Company Profiles
11.1. Adma Biologics
11.2. Arthrex
11.3. Bio Products Laboratory
11.4. Baxter International
11.5. Biotest Ag
11.6. Cerus Corporation (Cerus)
11.7. China Biologic Products
11.8. Csl Limited
11.9. Fusion Health Care
11.10. Green Cross Holdings Corporation
11.11. Grifols
11.12. Lfb
11.13. Octapharma
11.14. Takeda Pharmaceutical Company
11.15. Kedrion Biopharma Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Immunoglobulin Infusions Side Effects
Figure 6: Role Of Fibrin Sealant In Coagulation Cascade
Figure 7: Asia Pacific Blood Plasma Market, By Disorder, In 2019
Figure 8: Asia Pacific Blood Plasma Market, By Immunodeficiency Disease, 2020-2028 (In $ Million)
Figure 9: Asia Pacific Blood Plasma Market, By Hypogammaglobulinemia, 2020-2028 (In $ Million)
Figure 10: Asia Pacific Blood Plasma Market, By Hemophilia, 2020-2028 (In $ Million)
Figure 11: Asia Pacific Blood Plasma Market, By Von Willebrand Disease (Vwd), 2020-2028 (In $ Million)
Figure 12: Asia Pacific Blood Plasma Market, By Other Disorders, 2020-2028 (In $ Million)
Figure 13: Asia Pacific Blood Plasma Market, By Blood Derivatives, In 2019
Figure 14: Asia Pacific Blood Plasma Market, By Immunoglobulin, 2020-2028 (In $ Million)
Figure 15: Asia Pacific Immunoglobulin Market, By Intravenous Immunoglobulin, 2020-2028 (In $ Million)
Figure 16: Asia Pacific Immunoglobulin Market, By Subcutaneous Immunoglobulin, 2020-2028 (In $ Million)
Figure 17: Asia Pacific Immunoglobulin Market, By Other Immunoglobulin Types, 2020-2028 (In $ Million)
Figure 18: Asia Pacific Blood Plasma Market, By Albumin, 2020-2028 (In $ Million)
Figure 19: Asia Pacific Blood Plasma Market, By Hyperimmune, 2020-2028 (In $ Million)
Figure 20: Hyperimmunes Isolation Process
Figure 21: Asia Pacific Blood Plasma Market, By Coagulation Factor Concentrates, 2020-2028 (In $ Million)
Figure 22: Asia Pacific Blood Plasma Market, By Other Plasma Fractionation Products, 2020-2028 (In $ Million)
Figure 23: Asia Pacific Blood Plasma Market, By Therapeutic Indication, In 2019
Figure 24: Asia Pacific Blood Plasma Market, By Neurology, 2020-2028 (In $ Million)
Figure 25: Asia Pacific Blood Plasma Market, By Immunology, 2020-2028 (In $ Million)
Figure 26: Asia Pacific Blood Plasma Market, By Oncology, 2020-2028 (In $ Million)
Figure 27: Asia Pacific Blood Plasma Market, By Transplantation, 2020-2028 (In $ Million)
Figure 28: Asia Pacific Blood Plasma Market, By Hematology, 2020-2028 (In $ Million)
Figure 29: Asia Pacific Blood Plasma Market, By Rheumatology, 2020-2028 (In $ Million)
Figure 30: Lupus Infection Symptoms
Figure 31: Asia Pacific Blood Plasma Market, By Pulmonology, 2020-2028 (In $ Million)
Figure 32: Asia Pacific Blood Plasma Market, By Other Therapeutic Indication, 2020-2028 (In $ Million)
Figure 33: Asia Pacific Blood Plasma Market, By End-User, In 2019
Figure 34: Asia Pacific Blood Plasma Market, By Hospitals And Clinics, 2020-2028 (In $ Million)
Figure 35: Asia Pacific Blood Plasma Market, By Research Laboratories, 2020-2028 (In $ Million)
Figure 36: Asia Pacific Blood Plasma Market, By Academic Institutions, 2020-2028 (In $ Million)
Figure 37: Asia Pacific Blood Plasma Market, Country Outlook, 2019 & 2028 (In %)
Figure 38: Japan Blood Plasma, 2020-2028 (In $ Million)
Figure 39: China Blood Plasma, 2020-2028 (In $ Million)
Figure 40: Australia & New Zealand Blood Plasma, 2020-2028 (In $ Million)
Figure 41: India Blood Plasma, 2020-2028 (In $ Million)
Figure 42: South Korea Blood Plasma Market, 2020-2028 (In $ Million)
Figure 43: Thailand Blood Plasma Market, 2020-2028 (In $ Million)
Figure 44: Indonesia Blood Plasma Market, 2020-2028 (In $ Million)
Figure 45: Vietnam Blood Plasma Market, 2020-2028 (In $ Million)
Figure 46: Rest Of Asia Pacific Blood Plasma Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - BLOOD PLASMA
TABLE 2: ASIA PACIFIC BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: ASIA PACIFIC BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: ASIA PACIFIC BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: ASIA PACIFIC BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: ASIA PACIFIC BLOOD PLASMA, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: ASIA PACIFIC BLOOD PLASMA, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)